The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Diehl, K., Hull, R., Morton, D., Pfister, R., Rabemampianina, Y., Smith, D., Vidal, J., & Vorstenbosch, C. V. D. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.727 · Cited by 1,562
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Lown, K. S., Mayo, R. R., Leichtman, A. B., Hsiao, H.-L., Turgeon, D. K., Schmiedlin-Ren, P., Brown, M. B., Guo, W., Rossi, S. J., Benet, L. Z., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90027-8 · Cited by 680
Chemistry and Biology of Taxol
Nicolaou, K. C., Dai, W., & Guy, R. K. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199400151 · Cited by 623
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., & Benoit, J.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016121319668 · Cited by 583
Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M., & Hageman, M. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10511 · Cited by 361
Role of Formulation Vehicles in Taxane Pharmacology
van Zuylen, L., Verweij, J., & Sparreboom, A. (2001) · Investigational New Drugs · doi:10.1023/a:1010618632738 · Cited by 293
Caliph, S. M., Charman, W. N., & Porter, C. J. H. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v · Cited by 292
Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.018 · Cited by 255
Lipids, Lipophilic Drugs, and Oral Drug Delivery—Some Emerging Concepts
Charman, W. N. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<967::aid-jps1>3.0.co;2-r · Cited by 224
Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
Terwogt, J. M. M., Malingré, M. M., Beijnen, J. H., Huinink, W. W. T. B., Rosing, H., Koopman, F. J., van Tellingen, O., Swart, M., & Schellens, J. H. M. (1999) · PubMed · Cited by 205
van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A., Borst, P., Nooijen, W., & Beijnen, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.530 · Cited by 202
In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits
Jiao, Y., Ubrich, N., Marchand-Arvier, M., Vigneron, C., Hoffman, M., Lecompte, T., & Maincent, P. (2002) · Circulation · doi:10.1161/hc0202.101988 · Cited by 200
Yang, S., Gursoy, R. N., Lambert, G., & Benita, S. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016238.44452.f1 · Cited by 169
Aprahamian, M., Michel, C., Humbert, W., Devissaguet, J. P., & Damge, C. (1987) · Biology of the Cell · doi:10.1111/j.1768-322x.1987.tb00571.x · Cited by 163
Malingré, M. M., Beijnen, J. H., & Schellens, J. H. M. (2001) · Investigational New Drugs · doi:10.1023/a:1010635000879 · Cited by 158
Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams, J. D., Flora, K. P., Goldspiel, B. R., Wilson, J., Arbuck, S. G., & Finley, R. W. (1993) · PubMed · Cited by 157
New lipid nanocapsules exhibit sustained release properties for amiodarone
Lamprecht, A., Bouligand, Y., & Benoît, J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00258-4 · Cited by 138
Self-citationvan Asperen, J., van Tellingen, O., van der Valk, M. A., Rozenhart, M., & Beijnen, J. H. (1998) · PubMed · Cited by 138
Woo, J. S., Lee, C. H., Shim, C. K., & Hwang, S. (2003) · Pharmaceutical Research · doi:10.1023/a:1022286422439 · Cited by 133
Bardelmeijer, H. A., Beijnen, J. H., Brouwer, K. R., Rosing, H., Nooijen, W. J., Schellens, J. H. M., & van Tellingen, O. (2000) · PubMed · Cited by 121
Kruijtzer, C. M. F., Beijnen, J. H., & Schellens, J. H. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-516 · Cited by 110
Human Plasma Distribution of Free Paclitaxel and Paclitaxel Associated with Diblock Copolymers
Ramaswamy, M., Zhang, X., Burt, H. M., & Wasan, K. M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960333n · Cited by 99
Formulating Paclitaxel in Nanoparticles Alters Its Disposition
Yeh, T. K., Lu, Z., Wientjes, M. G., & Au, J. L. ‐. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4581-4 · Cited by 90
Hepatic metabolism and biliary excretion of Taxol in rats and humans.
Monsarrat, B., Alvinerie, P., Wright, M. R., et al. (1993) · PubMed · Cited by 72
Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying
Dulieu, C., & Bazile, D. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1196-0 · Cited by 55
de Oliveira, M. P., Garcion, E., Venisse, N., Benoît, J., Couet, W. R., & Olivier, J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7147-6 · Cited by 47
Self-citationMalingré, M. M., Beijnen, J. H., Rosing, H., Koopman, F. J., van Tellingen, O., Duchin, K., Huinink, W. W. T. B., Swart, M., Lieverst, J. A., & Schellens, J. H. M. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000226 · Cited by 44
Cited by
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 606
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
Lu, Y., & Park, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.042 · Cited by 572
“Data from oral administration indicated an stimated bioavailability of 12.4%, which is significantly higher han reported 6.5% (Peltier et al., 2006) for Cremophor EL micelle ormulation of paclitaxel (Taxol®) given orally.”
InfluentialMilk-derived exosomes for oral delivery of paclitaxel
Agrawal, A. K., Aqil, F., Jeyabalan, J., Spencer, W. A., Beck, J., Gachuki, B. W., Alhakeem, S. S., Oben, K., Munagala, R., Bondada, S., et al. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.03.001 · Cited by 542
Metadata
- Authors
- Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P.
- Venue
- Pharmaceutical Research
- Published
- 2006-05-25
- Volume
- 23
- Issue
- 6
- Pages
- 1243-1250
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2058958377
- Cited by
- 274
- References
- 32
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.